PT1711473E - N-ciclo-hexilimidazolinonas substituídas com acção moduladora de mch - Google Patents

N-ciclo-hexilimidazolinonas substituídas com acção moduladora de mch Download PDF

Info

Publication number
PT1711473E
PT1711473E PT05707002T PT05707002T PT1711473E PT 1711473 E PT1711473 E PT 1711473E PT 05707002 T PT05707002 T PT 05707002T PT 05707002 T PT05707002 T PT 05707002T PT 1711473 E PT1711473 E PT 1711473E
Authority
PT
Portugal
Prior art keywords
cyclohexylimidazolinones
mch
substituted
modulatory effect
modulatory
Prior art date
Application number
PT05707002T
Other languages
English (en)
Inventor
Siegfried Stengelin
Thomas Boehme
Lothar Schwink
Matthias Gossel
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of PT1711473E publication Critical patent/PT1711473E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/08Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/08Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
PT05707002T 2004-01-25 2005-01-25 N-ciclo-hexilimidazolinonas substituídas com acção moduladora de mch PT1711473E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004003811A DE102004003811A1 (de) 2004-01-25 2004-01-25 Substituierte N-Cyclohexylimidazolinone, Verfahren ihrer Herstellung und ihre Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
PT1711473E true PT1711473E (pt) 2008-03-07

Family

ID=34745115

Family Applications (1)

Application Number Title Priority Date Filing Date
PT05707002T PT1711473E (pt) 2004-01-25 2005-01-25 N-ciclo-hexilimidazolinonas substituídas com acção moduladora de mch

Country Status (26)

Country Link
EP (1) EP1711473B1 (pt)
JP (1) JP2007518771A (pt)
KR (1) KR20060128955A (pt)
CN (1) CN1934090B (pt)
AR (1) AR047453A1 (pt)
AT (1) ATE383342T1 (pt)
AU (1) AU2005206308A1 (pt)
BR (1) BRPI0507104A (pt)
CA (1) CA2554233A1 (pt)
CY (1) CY1107429T1 (pt)
DE (2) DE102004003811A1 (pt)
DK (1) DK1711473T3 (pt)
ES (1) ES2297667T3 (pt)
HR (1) HRP20080077T3 (pt)
IL (1) IL176917A0 (pt)
MA (1) MA28345A1 (pt)
MY (1) MY139107A (pt)
NO (1) NO20063757L (pt)
PE (1) PE20051091A1 (pt)
PL (1) PL1711473T3 (pt)
PT (1) PT1711473E (pt)
RS (1) RS50543B (pt)
RU (1) RU2006130626A (pt)
TW (1) TW200604182A (pt)
UY (1) UY28726A1 (pt)
WO (1) WO2005070898A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1966164B1 (en) 2005-12-21 2013-03-06 Janssen Pharmaceutica N.V. Novel substituted pyrazinone derivatives for use in mch-1 mediated diseases
MX2009001043A (es) 2006-08-08 2009-02-06 Sanofi Aventis Imidazolidina-2,4-dionas sustituidas con arilaminoarilalquilo, procedimiento para preparalas, medicamentos que comprenden estos compuestos y su uso.
JP5290192B2 (ja) 2006-12-05 2013-09-18 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Mch−1に媒介される疾患における使用のための新規な置換されたジアザ−スピロ−ピリジノン誘導体
KR100893394B1 (ko) * 2007-05-11 2009-04-17 한국화학연구원 아릴 피페리딘기-함유 이미다졸 유도체, 이의 제조방법 및이를 유효성분으로 포함하는 약학적 조성물
US8470841B2 (en) 2008-07-09 2013-06-25 Sanofi Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
DE102008060967A1 (de) * 2008-12-06 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Substituierte Phenylsulfonyltriazolone und ihre Verwendung
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
ES2443016T3 (es) 2009-08-26 2014-02-17 Sanofi Nuevos hidratos cristalinos de fluoroglicósidos heteroaromáticos, productos farmacéuticos que comprenden estos compuestos, y su empleo
US8809325B2 (en) 2011-03-08 2014-08-19 Sanofi Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof
WO2012120054A1 (de) 2011-03-08 2012-09-13 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120058A1 (de) 2011-03-08 2012-09-13 Sanofi Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120050A1 (de) 2011-03-08 2012-09-13 Sanofi Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
US8710050B2 (en) 2011-03-08 2014-04-29 Sanofi Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
US8895547B2 (en) 2011-03-08 2014-11-25 Sanofi Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
US8871758B2 (en) 2011-03-08 2014-10-28 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
EP2766349B1 (de) 2011-03-08 2016-06-01 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
US8828995B2 (en) 2011-03-08 2014-09-09 Sanofi Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
PL223830B1 (pl) 2012-04-03 2016-11-30 Univ Jagielloński Pochodne aromatycznych imidazolidynonów i ich zastosowanie

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1453501B1 (en) * 2001-12-04 2008-08-13 Schering Corporation N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
DE10233817A1 (de) * 2002-07-25 2004-02-12 Aventis Pharma Deutschland Gmbh Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
HRP20080077T3 (en) 2008-03-31
PL1711473T3 (pl) 2008-05-30
AR047453A1 (es) 2006-01-18
ATE383342T1 (de) 2008-01-15
PE20051091A1 (es) 2006-01-23
TW200604182A (en) 2006-02-01
EP1711473A1 (de) 2006-10-18
UY28726A1 (es) 2005-08-31
ES2297667T3 (es) 2008-05-01
DE502005002497D1 (de) 2008-02-21
CA2554233A1 (en) 2005-08-04
BRPI0507104A (pt) 2007-06-19
RU2006130626A (ru) 2008-02-27
KR20060128955A (ko) 2006-12-14
MA28345A1 (fr) 2006-12-01
MY139107A (en) 2009-08-28
DE102004003811A1 (de) 2005-08-11
CN1934090A (zh) 2007-03-21
DK1711473T3 (da) 2008-05-26
IL176917A0 (en) 2006-12-10
NO20063757L (no) 2006-10-11
JP2007518771A (ja) 2007-07-12
AU2005206308A1 (en) 2005-08-04
RS50543B (sr) 2010-05-07
CN1934090B (zh) 2010-04-07
EP1711473B1 (de) 2008-01-09
CY1107429T1 (el) 2012-12-19
WO2005070898A1 (de) 2005-08-04

Similar Documents

Publication Publication Date Title
PT1711473E (pt) N-ciclo-hexilimidazolinonas substituídas com acção moduladora de mch
EP1717239A4 (en) SUBSTITUTED SYM TRIINDOLE
DE602005020252D1 (en) Röhrenförmige prothese
AP2006003810A0 (en) 4-Phenylamino-quinazolin-6-yl-amides
DE602005010905D1 (en) Roboterhandvorrichtung
DE602005007474D1 (en) Substituierte morpholin- und thiomorpholinderivate
DE602005011286D1 (en) Pyrazolopyridinderivate
DE602004014986D1 (en) Terminal-box
DE502005007456D1 (en) Nanoemulsionen
DE602005008719D1 (en) Notinformationsschild
EP1732560A4 (en) SUBSTITUTED CINNOLINE-4-YLAMINE
DE602005010119D1 (en) Roboterhandvorrichtung
DE602005010440D1 (en) Lymerdispersionen
DE602005025096D1 (en) Rotationsdämpfer
DE502005009795D1 (en) Modulares gelenkprothesensystem
DE602005003029D1 (en) Polyaminoamidmonoepoxyaddukte
DE502004004685D1 (en) Giessmaschine
IL180888A0 (en) Substituted n-acyl-2-aminothiazoles
DE502005010653D1 (en) Eiten
GB2418949B (en) Screwpiles
GB2411010B (en) Anomaloscope
DE502005006813D1 (en) Common-rail-injektor
DE502004004917D1 (en) Multiaxialkomplex
ZA200700723B (en) Substituted N-acyl-2-aminothiazoles
SI1711473T1 (sl) Substituirani N-cikloheksilimidazolinoni z MCH-modulatornim ucinkom